F
58
11
DD
63
3
YUM
47
3
CHRW
56
-3
INTU
56
-4
GPC
40
3
AN
58
4
DOW
44
10
VTR
47
-7
WDC
47
4
PFE
23
7
M
37
12
PSA
58
2
ROK
62
15
ACN
52
3
LLY
37
-3
FLR
58
3
LNC
39
3
CL
58
2
NWL
53
3
F
58
11
DD
63
3
YUM
47
3
CHRW
56
-3
INTU
56
-4
GPC
40
3
AN
58
4
DOW
44
10
VTR
47
-7
WDC
47
4
PFE
23
7
M
37
12
PSA
58
2
ROK
62
15
ACN
52
3
LLY
37
-3
FLR
58
3
LNC
39
3
CL
58
2
NWL
53
3
Financhill
Back

AbbVie 10K Form

Sell
40

ABBV
AbbVie

Last Price:
176.93
Seasonality Move:
6.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-03 10Q ABBV/AbbVie Quarterly
2023-11-06 10Q ABBV/AbbVie Quarterly
2023-08-07 10Q ABBV/AbbVie Quarterly
2023-05-05 10Q ABBV/AbbVie Quarterly
2022-11-04 10Q ABBV/AbbVie Quarterly
2022-08-04 10Q ABBV/AbbVie Quarterly

Receive ABBV News And Ratings

See the #1 stock for the next 7 days that we like better than ABBV

ABBV Financial Statistics

Sales & Book Value

Annual Sales: $54.32B
Cash Flow: $5.2B
Price / Cash Flow: 20.08
Annual Sales: $3.41
Price / Book: 51.84

Profitability

EPS (TTM): 2.88000
Net Income (TTM): $5.12B
Gross Margin: $33.9B
Return on Equity: 58.92%
Return on Assets: 3.63%

AbbVie Earnings Forecast

Key AbbVie Financial Ratios

  • The Gross Profit Margin over the past 15 years for ABBV is 62.42%.
  • The Selling, General & Administrative Expenses for ABBV have been equal to 23.70% of Gross Profit Margin.
  • The Research & Development expenses have been 15.56% of Revenue.
  • The Interest Expense is 45.73% of Operating Income.
  • The Net Earning history of ABBV is 8.95% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 7 years.

AbbVie Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: ABBV
CUSIP: 00287Y
Website: abbvieinvestor.com

Debt

Debt-to-Equity Ratio: 11.78
Current Ratio: 0.65
Quick Ratio: 0.44

Price-to-Earnings

Trailing P/E Ratio: 65.06
Forward P/E Ratio: 14.57

ABBV Technical Analysis vs Fundamental Analysis

Sell
40
AbbVie (ABBV) is a Sell

Is AbbVie a Buy or a Sell?

  • AbbVie stock is rated a Sell
    The current AbbVie [ABBV] share price is $176.95. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.